<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The prognostic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of the World Health Organization category of "systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> with associated clonal hematologic nonmast cell lineage disease" (<z:e sem="disease" ids="C1301365" disease_type="Neoplastic Process" abbrv="">SM-AHNMD</z:e>) has not been systematically validated by primary data </plain></SENT>
<SENT sid="1" pm="."><plain>Among 138 consecutive cases with <z:e sem="disease" ids="C1301365" disease_type="Neoplastic Process" abbrv="">SM-AHNMD</z:e>, 123 (89%) had associated myeloid <z:hpo ids='HP_0002664'>neoplasm</z:hpo>: 55 (45%) myeloproliferative <z:hpo ids='HP_0002664'>neoplasm</z:hpo> (SM-MPN), 36 (29%) <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, 28 (23%) <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (SM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and 4 (3%) <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Of the myeloid subgroups, SM-MPN displayed a 2- to 3-fold better life expectancy (P = .003), whereas leukemic transformation was more frequent in SM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (29%; P = .02) </plain></SENT>
<SENT sid="3" pm="."><plain>The presence of <z:hpo ids='HP_0001880'>eosinophilia</z:hpo>, although prevalent (34%), was prognostically neutral, and the overall results were not affected by exclusion of FIP1L1-PDGFRA-positive cases </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that it is clinically more useful to consider specific entities, such as SM-MPN, systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> with <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, SM-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>, and systemic <z:hpo ids='HP_0100495'>mastocytosis</z:hpo> with-<z:hpo ids='HP_0002488'>acute leukemia</z:hpo>, rather than their broad reference as <z:e sem="disease" ids="C1301365" disease_type="Neoplastic Process" abbrv="">SM-AHNMD</z:e> </plain></SENT>
</text></document>